Morgan HealthJPMorgan Chase’s healthcare business unit, announced that Dr. Cheryl Pegas will support the company’s strategic investment aimed at closing the healthcare gap, working closely with Dan Hartman and Jeff Rees, who will lead the company’s ventures and Lead investment efforts.
Pegas previously served as executive vice president for health and wellness at Walmart, where she helped launch consumer health programs, broaden access to telehealth services and oversaw the company’s COVID-19 response.
Morgan Health CEO Dan Mendelson said in a statement, “Cheryl is one of the most respected leaders in healthcare and brings clinical and healthcare business expertise that will help accelerate the next phase of Morgan Health’s strategy around population health. ” “She is also a cardiologist and health equity expert and will be instrumental in our work to invest in and scale companies making a meaningful difference in reversing the trend of chronic disease, especially diabetes and heart disease, in the commercial market. She recognizes the opportunity we have to improve health outcomes for our employees and the more than 150 million Americans who rely on employer-sponsored insurance.”
Morgan Health announced in September that it had a $20M strategic investment in home diagnostics startup and Irish unicorn LetsGetChecked as part of Series D round.
JP Morgan company also invested $50 million in Vera Whole Health, an integrated primary care provider. Through their partnership, with participation from Central Ohio Primary Care, the companies opened three primary care centers for employees in Ohio and two nearby care centers for employees and their families.
The company has also invested in data firm Embold Health and Tech-Enabled Health Plan Sentivo.
surgical training platform Fundamental VR announced that it has expanded its executive team with the appointments of Michele Hulsne, Erin Kullgren, Dottie Barrett and Myn Vendro.
Halsne will be vice president of sales, Kullgren will be vice president of development, Barrett will be vice president of strategic data commercialization and Wenderow will lead market strategy and execution.
Recent hires mean that 55% of FundamentalVR’s executive team is now made up of women.
“We are excited to welcome four amazing women to the FundamentalVR team and look forward to their contributions as we continue to expand into North America and Asia,” Richard Vincent, co-founder and CEO of FundamentalVR, said in a statement. ” “Throughout 2022, we continue to invest in our platform to transform the way surgical skills are acquired in a scalable, low-cost and multi-user environment. Erin, Michelle, Mayan and Dottie are committed to accessing FundamentalVR and better serving new customers. will be integral to helping deliver that vision.”
Mass-based VR company announces it has scored $20 million in Series B funding in August, led by EQT Life Sciences and joined by previous investor Downing Ventures, bringing its total raised to more than $30 million. It closed a $5 million Series A round in 2019.
addiction care startup Eleanor Health announced that it has appointed Elizabeth Hart as its Chief Customer and Patient Engagement Officer, Scott Fries as its Chief Financial Officer and Peter Byrd as its Chief of Staff. Danica Patterson was also promoted to head of markets.
The company, which provides in-person and virtual psychotherapy, therapy, recovery coaching and medication-assisted treatment for substance use disorders, said the new hires will support the growth and expansion of the company’s healthcare delivery model.
Hart joins Eleanor Health from Direct Primary and mental health care provider Everside Health, where she served as Vice President of Patient Engagement.
Fries’ previous experience includes eight years as chief operating officer, executive vice president and senior vice president of experience at AllScripts and Prime Therapeutics, followed by nine years as chief financial officer at UnitedHealthcare and Optum.
Bird joins Eleanor Health from Carolina Complete Networks, where he served as vice president of strategy and performance. As chief of staff at Eleanor, he will be responsible for board support, strategic planning processes, leadership team cadence and selecting strategic projects.
“We are thrilled to expand and expand our senior leadership team,” Corbin Petro, cofounder and CEO of Eleanor Health, said in a statement. “This is an exciting time for all of us at Eleanor, as we continue to improve our ability to both effectively and sustainably deliver our transformational care model, and value and succeed in population-based partnerships “
In April, Eleanor Health announced the acquisition of $50 million in Series C funding led by General Catalyst. Less than a year ago, the hybrid mental health and addiction care startup raised $20 million in Series B funding.
Home Diagnostics Company Q Health has appointed Dr. Josh Ghaim and Dr. Sachin Jain to its Board of Directors, which consists of seven Directors, five of whom are independent.
Ghaim joined the board on 21 July and Jain on 7 October.
Gaim is the founder and managing partner of Ignite Venture Studios, a company that assists growing digital health, wellness and beauty brands.
Jain serves as the President and CEO of Scan Group and is an Assistant Professor of Medicine at Stanford. he was the first CEO of Caremore, a chronic condition management company, and Aspire Health, which provides in-home and virtual palliative care services.
“On behalf of the management team and board, I am pleased to welcome both Josh and Sachin to the Q team. We are excited to bring extensive knowledge of health plans and payers as well as a physician perspective on Q’s board. We are furthering our vision of making healthcare more convenient, accessible and timely by placing clinical information at the center of care,” said Ayub Khattak, President and CEO, Q Health.
Q, known for its at-home molecular COVID-19 test, Goes public in 2021 with a $200 million IPO.
The diagnostics company had announced this in June this year. Considerable economic challenges and the federal government’s decision to remove funding from COVID-19 tests laid off 170 manufacturing workers.